EMA
approval
· 2022-01-28
New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma
Summary
The EMA announces a new gene therapy for patients with relapsed or refractory large B-cell lymphoma, representing a pivotal development in treatment options for…
Upgrade for the full analysis, importance score, and drug timeline.